Literature DB >> 9375126

A teleradiology case conference system.

T N Teslow1, R A Gilbert, W H Grant, S Y Woo, E B Butler, J H Liem.   

Abstract

To investigate the use of teleradiology in the quality assurance programme of a multicentre radiotherapy practice, we installed image acquisition and display workstations at each of two affiliated radiation oncology clinics. A commercial diagnostic teleradiology system was successfully modified to suit the requirements of the radiotherapy subspecialty. The system allowed intersite transmission of images, access to high-resolution images from each site and, by use of laser film scanners, made accessible all types of radiation therapy image. Transmission speed and storage capacity were better than expected. Using the system, radiation oncology residents and staff reviewed 83 complex cases over eight months. Case presentation and discussion were enhanced. In the same period, 276 cases were reviewed by conference in person. Case conferences for quality assurance conducted with the teleradiology system influenced changes in treatment planning as effectively as those conducted in person. Equivalent treatment outcomes were produced. The teleradiology system facilitated quality assurance through review of patients' radiation treatments by allowing natural interactive consultation.

Entities:  

Mesh:

Year:  1995        PMID: 9375126     DOI: 10.1177/1357633X9500100205

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  3 in total

Review 1.  Assessing telemedicine: a systematic review of the literature.

Authors:  R Roine; A Ohinmaa; D Hailey
Journal:  CMAJ       Date:  2001-09-18       Impact factor: 8.262

2.  The laser film digitizer: density, contrast, and resolution.

Authors:  T N Teslow
Journal:  J Digit Imaging       Date:  1997-08       Impact factor: 4.056

3.  A bridge between academic and community radiation oncology treatment planning.

Authors:  Patrick D Maguire; Geoff Honaker; Charles Neal; Martin Meyerson; David Morris; Julian Rosenman; Joel Tepper
Journal:  J Oncol Pract       Date:  2007-09       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.